Colli-Pee Self-Sampling Device Could Improve HPV Screening Access
Self-sampling with the Colli-Pee device could significantly expand access to cervical cancer screening for underserved and rural populations.
Read MorePosted by Melanie Hamilton-Basich | Jun 15, 2023 | Cervical (HPV), Urinalysis & Toxicology |
Self-sampling with the Colli-Pee device could significantly expand access to cervical cancer screening for underserved and rural populations.
Read MorePosted by Melanie Hamilton-Basich | Jun 7, 2023 | Covid 19, Molecular Diagnostics, POC Reagents & Test Kits |
Cue Health has received De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use.
Read MorePosted by Chris Wolski | Jun 2, 2023 | Controls |
Quality controls with lower cardiac troponin concentrations are needed to monitor and validate hs-cTn assay performance.
Read MorePosted by Melanie Hamilton-Basich | Jun 2, 2023 | Company News |
With the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Point-of-Care |
Orchard Software has partnered with Emerus Holdings Inc. for implementation of its Orchard Point-of-Care testing solution.
Read More